
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
A generic drug is similar to a brand-name drug in terms of dosage form, safety, strength, clinical performance, and intended use, among others. Generic medicines are generally available at a lower price and act as an equal substitute for their branded counterparts. In Asia Pacific, the rising burden of chronic diseases and the growing aging population are fuelling the need for affordable healthcare solutions, leading to the expansion of the global generic drugs market. Additionally, as policymakers in the region continuously introduce supportive measures for the promotion of generic medication uptake, the Asia Pacific generic drugs market demand is expected is witness a surge in the forecast period.
India is ranked as the largest manufacturer and exporter (by volume) of generic drugs, producing over 60,000 generic drugs across 60 therapeutic categories. It was reported that Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), a campaign–public welfare scheme of the Government of India to provide quality medicines at affordable prices through special outlets called Pradhan Mantri Bharatiya Janaushadhi Pariyojana Kendra, achieved an impressive generic medicines sales of INR 1000 crore in 2023. Moreover, people who purchased medicines from these outlets saved around INR 5,000 crore. The government further plans to open 25,000 such Janaushadhi Kendras across the country by March 2026. Such government initiatives that can drive substantial healthcare cost savings are projected to bolster the Asia Pacific generic drugs market growth.
One of the major market trends is the rise in patent expirations of branded drugs which allows the market entry of various generic medications, thereby increasing their access to the growing patient pool. In July 2023, it was reported that at least three Indian pharmaceutical companies, Lupin Limited, Natco Pharma, and Macleods Pharmaceuticals Ltd, are poised to manufacture generic versions of Johnson & Johnson’s tuberculosis drug Bedaquiline following its patent expiration. Thus, the increasing expiration of market exclusivity of brand-name products is likely to boost the market share and foster the production of the necessary generic medications.
Asia Pacific Generic Drugs Market Size
Asia Pacific Generic Drugs Market Analysis
Asia Pacific Generic Drugs Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market was valued at USD 48.7 billion driven by growth in government initiatives to ensure access to quality generic medicines at affordable prices across the region.
The market is anticipated to grow at a CAGR of 7.20% during the forecast period of 2025-2034 and is likely to reach a market value of USD 91.3 billion by 2034.
The rising burden of chronic diseases and the growing aging population are fuelling the demand for the market.
One of the significant trends in the market is the rise in government initiatives that promote the uptake of generic medications. For instance, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), an Indian campaign–public welfare scheme, achieved impressive generic medicines sales of INR 1000 crore in 2024.
Based on the therapy area, the market is segmented into cardiovascular, dermatology, respiratory, oncology, and rheumatology, among others.
By route of administration, the market is divided into oral, injectables, dermal/topical, and inhalers, among others.
The distribution channels of the market are hospital pharmacies, retail pharmacies, and online pharmacies, among others.
The market segmentation by countries includes China, Japan, and India, among others.
The key players in the market are Teva Pharmaceutical Industries Ltd, Viatris Inc., Sun Pharmaceutical Industries Ltd, Lupin, AstraZeneca, Baxter, Takeda Pharmaceutical Company Limited, GSK plc, Bausch + Lomb, Novartis AG, Sanofi, Pfizer Inc., Fresenius SE & Co. KGaA, and Aurobindo Pharma.
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124